Chris Markoch

Chris Markoch

InvestorPlace Contributor

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

Sundial Growers Is a Heavy Lift for Retail Investors

By Chris Markoch, InvestorPlace Contributor

Sundial Growers is not drawing much interest from institutional investors. That leaves SNDL stock with little reward for investors' efforts.

Bitcoin Is Marathon Digital Holding’s Greatest Strength and Greatest Weakness

By Chris Markoch, InvestorPlace Contributor

The primary reason for the MARA stock rally is its high correlation with Bitcoin. However if correlation equals causation than a prudent approach is needed.

GameStop Still Has More Questions Than Answers

By Chris Markoch, InvestorPlace Contributor

Ryan Cohen deserves time to execute his plan for GameStop. But that doesn’t mean you have to invest in GME stock while he does.

7 Meme Stocks to Buy After the Roblox IPO

By Chris Markoch, InvestorPlace Contributor

More stimulus means more money flowing into the stock market. Here are seven meme stocks that may benefit from the government’s largesse.

BioNano Genomics Is About the Future, Not the Present

By Chris Markoch, InvestorPlace Contributor

BioNano may cause great disruption in the field of genetics. However, the payoff for investing in BNGO stock is likely to be years away.

Social Capital Hedosophia Holdings VI Is a Trade Now and Maybe an Investment Later

By Chris Markoch, InvestorPlace Contributor

Social Capital Hedosophia Holdings VI will likely find a target to bring public. But until that target is named, IPOF stock looks to be more of a trade than an investment.

Nio Must Continue to Manage Elevated Expectations

By Chris Markoch, InvestorPlace Contributor

The more Nio accomplishes, the more investors expect. But for NIO stock to reach the loftiest of investors' bullish projections, $60 needs to be the floor.

Don’t Rush Your Plans For This Canoo Trip

By Chris Markoch, InvestorPlace Contributor

Canoo has an intriguing, innovative design and business plan. But with production two years away, it's not time to go all-in on GOEV stock.

Zomedica Is Not For the Weak-Handed Investor

By Chris Markoch, InvestorPlace Contributor

Zomedica is launching a product that will bring revenue through the door. But with a small addressable market, ZOM stock may not have much upside.

Make Sure You See Ocugen Stock With Clear Eyes

By Chris Markoch, InvestorPlace Contributor

OCGN stock is a hot trade at this point in 2021. But it's important for investors to see the company's outlook clearly.

Load More